Edgar Schuck,Robert Lai,Ishani Savant Landry,Bhaskar Rege,Mai Miyamoto,Sadaharu Kotani,Kanta Horie
申请号:
US16609514
公开号:
US20200078306A1
申请日:
2018.05.30
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention provides a pharmaceutical composition comprising a PDE9 inhibitor. Specifically, the PDE9 inhibitor is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quin olin-4(5H)-one or pharmaceutically acceptable salts thereof.